title: Rituximab combined with chemotherapy for lymphoma during pregnancy.
authors.forename: J
authors.initials: J
authors.lastname: Rey
authors.forename: D
authors.initials: D
authors.lastname: Coso
authors.forename: V
authors.initials: V
authors.lastname: Roger
authors.forename: N
authors.initials: N
authors.lastname: Bouayed
authors.forename: N
authors.initials: N
authors.lastname: Belmecheri
authors.forename: V
authors.initials: V
authors.lastname: Ivanov
authors.forename: J A
authors.initials: JA
authors.lastname: Gastaut
authors.forename: R
authors.initials: R
authors.lastname: Bouabdallah
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019468:Disease Management; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D011262:Pregnancy Trimester, Second; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab